Voltar
Editorial Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

We have Vaccine for COVID-19! What to Recommend for Pregnant Women?

2021; Thieme Medical Publishers (Germany); Volume: 43; Issue: 02 Linguagem: Inglês

10.1055/s-0041-1726090

ISSN

1806-9339

Autores

Silvana Maria Quintana,

Tópico(s)

Pregnancy and Medication Impact

Resumo

On January 17, 2021, two vaccines were approved by ANVISA for emergency use to help combat COVID-19: Coronavac and Covishield/Oxford. The first vaccine is composed of inactivated (killed) viruses, was produced by the Chinese company Sinovac and in Brazil, will be produced by the Butantã Institute (São Paulo). The second is an adenovirus non-replicating viral vector vaccine and was produced by the pharmaceutical company Serum Institute of India in partnership with AstraZeneca/Oxford University. In Brazil, it will be produced by the Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro.

Referência(s)